TECregen
PrivateLast Round
Seed
Jan 8, 2026
Total Funding Raised
$12.6M
Company Overview
TECregen is a biotechnology company developing a new class of biologics, called thymopoietics, designed to regenerate the thymus and restore immune function.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TECregen Comps
Public and private peers based on sector, stage, and business model.
TECregen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 8, 2026 |
TECregen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JFG Life Sciences Foundation of the University of Basel | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
| LifeSpan Vision Ventures | Seed |
| CARMA FUND | Seed |
| High-Tech Gründerfonds | Seed |
| Eos | Seed |
| Zurcher Kantonalbank | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2026
Dr. Klaas Zuideveld appointed as new Chief Executive Officer.
- Jan 8, 2026
Dr. Bo Rode Hansen appointed Chairman of the Board of Directors.
TECregen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TECregen's valuation, stock price, and market status.
